A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

Clinical trial NCT00129519 · COMPLETED

Trial details

NCT number: NCT00129519
Sponsor: Graceway Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Basal Cell Carcinoma

Start date: 2004-01-01
Primary completion: 2006-01-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.